Registration was successful!
Please follow the link from the email sent to

Serbia to Start Producing Russia's Sputnik V Vaccine by May, RDIF Says

© AP Photo / Zoltan BaloghA vial containing Russian vaccine Sputnik V is shown by a nurse at the South Pest Central Hospital in Budapest, Hungary, Friday, Feb. 12, 2021, as the vaccination with Sputnik V against the new coronavirus begins in the country.
A vial containing Russian vaccine Sputnik V is shown by a nurse at the South Pest Central Hospital in Budapest, Hungary, Friday, Feb. 12, 2021, as the vaccination with Sputnik V against the new coronavirus begins in the country. - Sputnik International, 1920, 25.03.2021
Subscribe
MOSCOW (Sputnik) - The Russian Direct Investment Fund (RDIF) on Thursday announced that it had reached an agreement with Serbia's Torlak Institute to produce Russia's Sputnik V vaccine against the coronavirus in the country, with production expected to start by May 2021.

"[The] RDIF ... and Institute of Virology, Vaccines and Sera 'Torlak' announce the agreement to produce Sputnik V, the world's first registered vaccine against coronavirus, in Serbia. Serbia will become the first country in southern Europe to produce Sputnik V. The vaccine could be exported to other countries in the region at a later stage. Production of Sputnik V is due to start by May 2021 at facilities of the Torlak Institute", the RDIF said in a press release.

RDIF CEO Kirill Dmitriev thanked the Serbian government for its "constant support" and trust in the vaccine, recalling that Serbia was among the first countries to approve Sputnik V.

© Sputnik / Kirill Braga / Go to the photo bankRussian vaccine "Sputnik V" in the city hospital "Leninskaya CRH" in the city of Leninsk.
Serbia to Start Producing Russia's Sputnik V Vaccine by May, RDIF Says - Sputnik International, 1920, 25.03.2021
Russian vaccine "Sputnik V" in the city hospital "Leninskaya CRH" in the city of Leninsk.
"We are grateful to the President of Russia, Mr Vladimir Putin, the Government of the Russian Federation, and the Russian Direct Investment Fund for their support in preserving the health and lives of people in the Republic of Serbia. The production of the Sputnik V vaccine at the Torlak Institute will strengthen the capacities of our country to fight against the coronavirus pandemic and open new perspectives for the distribution of this vaccine in the region of southern Europe", Serbian Minister of Innovations and Technological Development Nenad Popovic said, as quoted in the press release.

In the meantime, Sputnik V has been approved in 55 countries, becoming the world's second vaccine in terms of being certified. According to research, it has an efficacy of 91.6 percent, and is effective against mutated coronavirus strains.

Newsfeed
0
To participate in the discussion
log in or register
loader
Chats
Заголовок открываемого материала